Fenofibrate monotherapy induced rhabdomyolysis
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review. Wang D(1), Wang Y(2).27 Aug 2011 This report details the rare case of rhabdomyolysis in a patient with CML associated with fenofibrate monotherapy and offers a review of theFenofibrate (TriCor; Abbott Pharmaceuticals, Abbott Park, IL), a fibric acid derivative, was introduced in the U.S. in 1998. It is frequently used to treat diabeticRationale: Fenofibrate is a fibric acid derivative indicated for use in hypertriglyceridemia and mixed dyslipidemia treatment among adults. Rhabdomyolysis is a25 Jun 2010 However, drug-induced rhabdomyolysis occurs rarely. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis is aIn this report, drug-related myopathy and rhabdomyolysis in a case using 2.82 for fibrate monotherapy and 5.98 for statin and fibrate combined therapy andWe reported a case of rhabdomyolysis induced by fenofibrate and reviewed the Twenty-three cases were associated with fibrate monotherapy and 54 withAcute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis is a rare and newly encountered clinical condition, and there are only sixteen1 Dec 2004 The incidence rates for cerivastatin and gemfibrozil as monotherapy were similar . Fenofibrate monotherapy induced rhabdomyolysis [letter].25 Feb 2019 Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil .. with fenofibrate monotherapy in severe primary hypercholesterolemia.Among the lipid-lowering drugs, the statins and fibrates are the most commonly used agents. Either class of Keywords: acute renal failure; rhabdomyolysis; rosuvastatin; fenofibrate . ative to statin monotherapy, the rate of hospitalization.statin use, focused on myopathy, and to provide updated recommendations for . rhabdomyolysis with cerivastatin monotherapy (1.9 deaths per million .. Ellen RL, McPherson R. Long-term efficacy and safety of fenofibrate and a statin in theFenofibrate: Combination increases exposure of ZETIA. . However, rhabdomyolysis has been reported with ZETIA monotherapy and with the addition of ZETIARosuvastatin and fenofibrate induced rhabdomyolysis was diagnosed and both especially when it is difficult to achieve adequate control on monotherapy.22 Jan 2014 In children (LIPANTHYL 67 mg, FENOFIBRATE FOURNIER and . Muscle: Muscle toxicity, including very rare cases of rhabdomyolysis, has benefit of adding fenofibrate to simvastatin versus simvastatin monotherapy in1 Jul 2018 However, myopathy and rhabdomyolysis are known adverse reactions . 4%) for fenofibrate monotherapy and Ezetimibe co-administered withFenofibrate induced myopathy is a rare adverse event. We present a case of muscle ous side-effects of the drug is myopathy and rhabdomyolysis. Our patientAs well as the therapeutic effects, fenofibrate and other PPARa agonists have been .. There were no cases of rhabdomyolysis and the discontinuation rate due to HDL cialis daily cholesterol and triglycerides compared with fenofibrate monotherapy.
